Our new Insights article out now in European Neuropsychopharmacology
We argue that poor control conditions in digital therapeutics trials risk misleading efficacy claims.
Let’s raise the bar for DTx trial design.
🔗 authors.elsevier.com/a/1l-8p,L21E...
@ecnp.eu
#DTx #MentalHealth #ClinicalTrials
